イギリスにおけるデルタ感染.

Real-world management of juvenile autoimmune liver disease.

United European gastroenterology journal·2018

Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.

Alimentary pharmacology & therapeutics·2018

Spectroscopic identification of r-process nucleosynthesis in a double neutron-star merger.

Nature·2017

Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.

Clinical and experimental immunology·2017

Pattern of Liver Disease Following High-Dose Cytosine Arabinoside (HDARAC) Therapy in Children with Acute Myeloid Leukemia.

Leukemia & lymphoma·2016

Autoimmune hepatitis: From mechanisms to therapy.

Revista clinica espanola·2016

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.

Journal of viral hepatitis·2026

Evolving cigarette and hand-rolling tobacco purchasing patterns ahead of smokefree generation legislation in Great Britain: a population study, 2020-2025.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026

Gender Differences in the Protective Effects of Social Participation on Depressive Symptom Trajectories Among Middle-Aged and Older Adults in China: A Nationwide Longitudinal Study.

Healthcare (Basel, Switzerland)·2026

Sex differences in fetal mortality in Spain: historical trends and social and biological determinants.

Gaceta sanitaria·2026

Temporal trend and influencing factors of high-risk pregnancy in China: a nationwide longitudinal analysis.

Frontiers in public health·2026

Two universal pathways in demographic transition.

Evolutionary human sciences·2026

関連する実験動画

イギリスにおけるデルタ感染.

関連する概念動画

Real-world management of juvenile autoimmune liver disease.

Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.

Spectroscopic identification of r-process nucleosynthesis in a double neutron-star merger.

Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.

Pattern of Liver Disease Following High-Dose Cytosine Arabinoside (HDARAC) Therapy in Children with Acute Myeloid Leukemia.

Autoimmune hepatitis: From mechanisms to therapy.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.

Evolving cigarette and hand-rolling tobacco purchasing patterns ahead of smokefree generation legislation in Great Britain: a population study, 2020-2025.

Gender Differences in the Protective Effects of Social Participation on Depressive Symptom Trajectories Among Middle-Aged and Older Adults in China: A Nationwide Longitudinal Study.

Sex differences in fetal mortality in Spain: historical trends and social and biological determinants.

Temporal trend and influencing factors of high-risk pregnancy in China: a nationwide longitudinal analysis.

Two universal pathways in demographic transition.

関連する実験動画

イギリスにおけるデルタ感染.

関連する概念動画

関連記事